日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tailoring Advanced Metal-Based Nanomedicines for Adaptable Nanodynamic Disease Therapies and Theranostics

定制先进的金属基纳米药物,用于可适应性纳米动力学疾病治疗和诊疗一体化

Ding, Qihang; Li, Wenhao; Mei, Ling; Luo, Suling; Tao, Jing; Shi, Chongxiu; Yang, Hongping; Feng, Wei; Chen, Yungchang; Chen, Yu; Kim, Jong Seung; Shen, Xue

Selenium-derived bioactive enablers for advanced therapies: From molecular redox modulation to broad-spectrum disease applications

硒衍生的生物活性促进剂在先进疗法中的应用:从分子氧化还原调控到广谱疾病治疗

Ding, Qihang; Shi, Chongxiu; Wu, Hao; Chen, Yin; Li, Wenhao; Yang, Hongping; Zhu, Liming; Ye, Li; Peng, Yongqi; Mei, Ling; Song, Tao; Chen, Yungchang; Liu, Yiyao; Shen, Xue

Acidic in vitro selection of metal-specific deoxyribozymes

酸性体外筛选金属特异性脱氧核酶

Jia, Pan; Chang, Yangyang; Li, Shen; Xue, Wei; Xiao, Shusen; Zhang, Qiang; Li, Jiuxing; Wang, Ying; Zhang, Zijie; Liu, Meng

Case Report: Imaging features of fetal intracranial immature teratoma

病例报告:胎儿颅内未成熟畸胎瘤的影像学特征

Cai, Tingting; Zhang, Wenwen; Qi, Linghong; Li, Qiongshan; Liu, Mingsong; Shen, Xue Ping; Li, Zhi

A Plug-in system for reprogramming the editing patterns of base editors.

用于重新编程基础编辑器编辑模式的插件系统。

Zhong Chaoyue, Yu Lan, Zhao Tingting, Shen Xue, Li Zhen, Zhu Wei, Hu Zheng, Tian Rui, Han Zhiqiang, He Dan

Microenvironment-responsive size-adaptive nanoparticles: hyaluronidase/acid/NIR light activation for deep-penetration trimodal therapy

微环境响应型尺寸自适应纳米颗粒:透明质酸酶/酸/近红外光激活,用于深层渗透三模式疗法

Wu, Hao; Li, Hongping; Li, Li; Chen, Yungchang; Yang, Hongping; Shi, Chongxiu; Li, Wenhao; Ye, Li; Zhu, Liming; He, Gang; Luo, Suling; Tao, Jing; Mei, Ling; Shen, Xue

Gain-of-function ANXA11 mutation cause late-onset ALS with aberrant protein aggregation, neuroinflammation and autophagy impairment

获得功能性 ANXA11 突变导致晚发型 ALS,伴有异常蛋白质聚集、神经炎症和自噬障碍

Qing Liu, Ye Sun, Baodong He, Haodong Chen, Lijing Wang, Gaojie Wang, Kang Zhang, Ximeng Zhao, Xinzhe Zhang, Dongchao Shen, Xue Zhang, Liying Cui

Herb-drug interactions in oncology: pharmacodynamic/pharmacokinetic mechanisms and risk prediction

肿瘤学中草药与药物的相互作用:药效学/药代动力学机制和风险预测

Duan, Xiaoyan; Fan, Xiaoyu; Jiang, Haiyan; Li, Jie; Shen, Xue; Xu, Zeao; Zhou, Ziqi; Xu, Jia; Chen, Chongze; Jin, Hongtao

Correction: Hou et al. S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer. Pharmaceuticals 2023, 16, 749

更正:Hou 等人,《新型口服微管蛋白抑制剂 S-72 通过抑制乳腺癌中的 STING 通路克服紫杉醇耐药性》,Pharmaceuticals 2023, 16, 749

Hou, Zhenyan; Lin, Songwen; Du, Tingting; Wang, Mingjin; Wang, Weida; You, Shen; Xue, Nina; Liu, Yichen; Ji, Ming; Xu, Heng; Chen, Xiaoguang

Novel therapies improve prognosis of IgAN and limit the applicability of the International IgA Nephropathy Prediction Tool

新型疗法改善了IgA肾病的预后,并限制了国际IgA肾病预测工具的适用性。

Shen, Xue; Chen, Pei; Liu, Lijun; Shi, Sufang; Zhou, Xujie; Barbour, Sean J; Lv, Jicheng; Zhang, Hong